Advertisement

Insulin infusion suppresses endotoxin-induced oxidative, nitrative and inflammatory stress in normal human subjects

      Our work over the past few years has demonstrated that insulin exerts anti-inflammatory and cardio-protective effects. We have now hypothesized that insulin reduces the magnitude of oxidative, nitrative and inflammatory response induced by endotoxin (LPS). Nine normal subjects were injected with 2 ng/Kg of LPS prepared from E. coli intravenously. Ten others were infused with insulin (2U/h) for 6 h in addition to the LPS injection along with 100 ml/hr of 5% dextrose was co-infused with insulin to maintain normoglycemia. LPS injection induced an increase in body temperature, pulse rate, body aches and headache. The subjects also exhibited a rapid increase in plasma concentrations of nitric oxide metabolites (NOM), nitrite and nitrate, TBARS, increase in ROS generation by PMNL and marked increases in plasma FFA, MIF, TNFa and IL-6 concentrations (Table1)The coinfusion of insulin led to significant reduction in body temperature (100.3 vs. 101.3 F, p< 0.005) and headache, a total elimination of the increase in NOM, FFA, TBARS and a significant reduction in ROS generation by PMNL and plasma MIF concentrations (Table 1). However, insulin did not affect TNFa and IL-6. Thus, insulin reduced clinical symptoms, oxidative, nitrative and inflammatory tress as induced by LPS. Insulin is a potential rational anti-inflammatory therapy for endotoxemia.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect